Comprehensive Care for Cirrhosis Patients

Initial Assessment and Monitoring

The American Association for the Study of Liver Diseases recommends evaluating the severity of cirrhosis using validated scoring systems such as MELD score, Child-Pugh score, and CLIF-SOFA score to guide management decisions and predict mortality 3, 4
Assessing for the number and severity of organ failures is crucial, as 28-day mortality ranges from 4.7% in patients without organ failure to 76.7% in patients with ACLF grade 3 5
Monitoring the evolution of SOFA score during ICU stay is critical, as scores >10 are predictive of mortality in 93% of cases 5
Reassessment of organ failure at day 3 and day 7 predicts outcomes better than initial assessment 5, 6

The European Association for the Study of the Liver recommends obtaining hepatology expert consultation immediately upon admission if the patient is already on a liver transplantation waiting list 5, 7
Expert hepatology advice should be sought soon after ICU admission to determine the appropriate intensity of care based on the number of organ failures and their progression 5
Consultation with experts is necessary when considering liver support techniques 5
Arranging hepatology follow-up at discharge is essential to organize ongoing management and evaluate potential for liver transplantation 5

The American College of Gastroenterology recommends initiating palliative care consultation for all patients with cirrhosis at hospital admission, especially those with ACLF or requiring ICU admission, to improve quality of life and reduce readmissions 1, 2, 8
Goals of care discussions should be conducted at key sentinel events, including hospital admission, ICU admission, before initiating life-supporting therapies, and after determination of transplant eligibility 9, 10
Assessing for symptoms across physical, psychological, social, and spiritual domains related to liver disease is essential 9
Screening for caregiver support needs, particularly for patients with decompensated disease, is necessary 9, 10
Evaluating for hospice referral for patients with comfort-oriented goals and a prognosis of 6 months or less is recommended 9

The American Association for the Study of Liver Diseases recommends assessing for and managing thromboembolism risk with appropriate prophylaxis, considering individual bleeding risk 6, 7
Intermittent pneumatic compression devices should be considered for patients at high risk of both thromboembolism and bleeding 6
Monitoring for and aggressively treating infections is crucial, as they are associated with high mortality in cirrhosis patients 4

The European Association for the Study of the Liver recommends not excluding patients from ICU admission solely based on their cirrhotic condition 4
Acute decompensation does not contraindicate liver transplantation and may actually prioritize the patient on the transplant list 5
Liver transplantation listing and palliative care services are not mutually exclusive 1, 8

Arranging hepatology follow-up to organize ongoing management and evaluate potential for liver transplantation is essential 5